Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_assertion type Assertion NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_head.
- NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_assertion description "[The frequency of miR-126 downregulation was 100.0% in FAP adenomas, 85.7% in FAP intramucosal carcinomas, 78.9% in invasive carcinomas, 81.3% in Lynch syndrome tumors, 68.4% in MSS tumors, and 65.4% in MSI-H tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_provenance.
- NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_assertion evidence source_evidence_literature NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_provenance.
- NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_assertion SIO_000772 24994098 NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_provenance.
- NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_assertion wasDerivedFrom befree-2016 NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_provenance.
- NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_assertion wasGeneratedBy ECO_0000203 NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_provenance.